Biblio
J
Jiang Y, Dai J, Zhang H, Sottnik JL, Keller JM, Escott KJ, Sanganee HJ, Yao Z, McCauley LK, Keller ET.
Activation of the Wnt pathway through use of AR79, a glycogen synthase kinase 3beta inhibitor, promotes prostate cancer growth in soft tissue and bone. Mol Cancer Res. 2013.